If you are looking for an undercovered story during this pandemic, take a look at the continued threat of antibiotic-resistant pathogens.
There isn’t a lot of data out there, but scientists are watching for signs that COVID-19 patients are being overtreated with antibiotics, which could lead to a surge in super bugs – the term for bacteria and fungus that are resistant to most, if not all, antibiotics.
Over the years, I’ve presented on reporting medical research findings. Some of the most common questions I get are about writing the findings using accessible language that an average person can understand. It’s particularly difficult when the outcome is reported in units like standard deviations, but reporting hazard ratios and odds ratios can be confusing as well, especially for those who only occasionally write about medical studies.
A new resource from the Winton Centre for Risk and Evidence Communication at Cambridge University in the UK can help you make sense of those findings and even provide the language and graphics to help your audience understand the results. RealRisk is the brainchild of professor David Spiegelhalter, the center’s chair, a statistician and author of The Art of Statistics, and Executive Director Alexandra Freeman, who told me more about the tool. Continue reading
The U.S. Supreme Court this month heard oral arguments in the case of Rutledge v. Pharmaceutical Care Management Association. At issue is the right of states to regulate pharmacy benefit management (PBMs) companies, which employers and health plans hire as middlemen to manage their prescription benefit programs for workers and other plan members.
During oral arguments on Oct. 6, several justices asked about the burden that health plans encounter when PBM regulations differ from one state to another, as Rachel Cohrs reported for Modern Healthcare. Continue reading
It’s no secret that humans are horrible at comprehending and estimating risk, especially when it comes to abstract numbers. It’s one reason (of several) that people fear encountering sharks at the beach more than the undertows that can drown them.
Misperceptions of risk have become an even more urgent life-or-death issue during the pandemic as a substantial number of people attempt to downplay the fatality rate. Continue reading
I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The two most important outcomes in vaccine trials are the vaccine’s safety and its efficacy. Recall that efficacy is different from effectiveness: efficacy refers to how well the vaccine prevents infection in the clinical trial, with effectiveness referring to how well it prevents infection in the real world with a broader and more diverse population. Continue reading
A new explainer from The Commonwealth Fund examines how the two presidential candidates will or have approached health issues of prime importance to older adults — Medicare, long-term care and caregiver support.
While it’s a bit like comparing apples and bananas, since only one side can point to any results, this issue brief nevertheless provides a helpful overview of what the U.S. has accomplished under a Trump presidency and how a Biden administration might differ. Continue reading